Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Communicable Diseases Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Communicable Diseases Therapeuticsmarket, defines the market attractiveness level of Communicable Diseases Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Communicable Diseases Therapeutics industry, describes the types of Communicable Diseases Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Communicable Diseases Therapeutics market and the development prospects and opportunities of Communicable Diseases Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Communicable Diseases Therapeutics market in Chapter 13.
By Player:
Merck
Boehringer Ingelheim
Roche
Gilead
GSK
Novartis
Janssen Pharmaceutical
BioCryst Pharmaceuticals
By Type:
HIV
Influenza
TB
Malaria
Hepatitis
HPV
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Communicable Diseases Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Communicable Diseases Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Communicable Diseases Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Communicable Diseases Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Communicable Diseases Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Communicable Diseases Therapeutics Consumption (2017-2022)
-
7.2 United States Communicable Diseases Therapeutics Consumption (2017-2022)
-
7.3 Europe Communicable Diseases Therapeutics Consumption (2017-2022)
-
7.4 China Communicable Diseases Therapeutics Consumption (2017-2022)
-
7.5 Japan Communicable Diseases Therapeutics Consumption (2017-2022)
-
7.6 India Communicable Diseases Therapeutics Consumption (2017-2022)
-
7.7 South Korea Communicable Diseases Therapeutics Consumption (2017-2022)
8 Region and Country-wise Communicable Diseases Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Communicable Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Communicable Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Communicable Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Communicable Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Communicable Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Communicable Diseases Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Communicable Diseases Therapeutics Consumption Forecast (2022-2028)
9 Global Communicable Diseases Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Communicable Diseases Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global HIV Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Influenza Consumption and Growth Rate (2017-2022)
-
9.1.3 Global TB Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Malaria Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Hepatitis Consumption and Growth Rate (2017-2022)
-
9.1.6 Global HPV Consumption and Growth Rate (2017-2022)
-
9.2 Global Communicable Diseases Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Communicable Diseases Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Communicable Diseases Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global TB Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Malaria Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global HPV Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Communicable Diseases Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Communicable Diseases Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Communicable Diseases Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Communicable Diseases Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Communicable Diseases Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Communicable Diseases Therapeutics Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Communicable Diseases Therapeutics Product and Service
-
14.2 Boehringer Ingelheim
-
14.2.1 Boehringer Ingelheim Company Details
-
14.2.2 Boehringer Ingelheim Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Boehringer Ingelheim Communicable Diseases Therapeutics Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Communicable Diseases Therapeutics Product and Service
-
14.4 Gilead
-
14.4.1 Gilead Company Details
-
14.4.2 Gilead Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Gilead Communicable Diseases Therapeutics Product and Service
-
14.5 GSK
-
14.5.1 GSK Company Details
-
14.5.2 GSK Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GSK Communicable Diseases Therapeutics Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Communicable Diseases Therapeutics Product and Service
-
14.7 Janssen Pharmaceutical
-
14.7.1 Janssen Pharmaceutical Company Details
-
14.7.2 Janssen Pharmaceutical Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Janssen Pharmaceutical Communicable Diseases Therapeutics Product and Service
-
14.8 BioCryst Pharmaceuticals
-
14.8.1 BioCryst Pharmaceuticals Company Details
-
14.8.2 BioCryst Pharmaceuticals Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 BioCryst Pharmaceuticals Communicable Diseases Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Communicable Diseases Therapeutics
-
Figure Communicable Diseases Therapeutics Picture
-
Table Global Communicable Diseases Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Communicable Diseases Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Communicable Diseases Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Communicable Diseases Therapeutics Consumption by Country (2017-2022)
-
Figure United States Communicable Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Communicable Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Communicable Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Communicable Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Communicable Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Communicable Diseases Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Communicable Diseases Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Communicable Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Communicable Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Communicable Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Communicable Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Communicable Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Communicable Diseases Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza Consumption and Growth Rate (2017-2022)
-
Figure Global TB Consumption and Growth Rate (2017-2022)
-
Figure Global Malaria Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis Consumption and Growth Rate (2017-2022)
-
Figure Global HPV Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TB Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Malaria Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HPV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Communicable Diseases Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Communicable Diseases Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Communicable Diseases Therapeutics Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Communicable Diseases Therapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Communicable Diseases Therapeutics Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Communicable Diseases Therapeutics Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Communicable Diseases Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Communicable Diseases Therapeutics Product and Service
-
Table Janssen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceutical Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceutical Communicable Diseases Therapeutics Product and Service
-
Table BioCryst Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table BioCryst Pharmaceuticals Communicable Diseases Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioCryst Pharmaceuticals Communicable Diseases Therapeutics Product and Service
-
